Table 1. Patient characteristics and treatment factors (n = 576).
| Characteristics | No. | (%) |
|---|---|---|
| Gender | ||
| Male | 443 | (76.9) |
| Female | 133 | (23.1) |
| Age (years) | ||
| Median (range) | 43 (13-78) | |
| WHO histological type§ | ||
| I | 1 | (0.2) |
| IIa | 56 | (9.7) |
| IIb | 519 | (90.1) |
| T-classification* | ||
| T1 | 96 | (16.7) |
| T2 | 152 | (26.4) |
| T3 | 235 | (40.8) |
| T4 | 93 | (16.1) |
| N-classification* | ||
| N0 | 78 | (13.5) |
| N1 | 320 | (55.6) |
| N2 | 150 | (26.0) |
| N3 | 28 | (4.9) |
| Clinical stage* | ||
| I | 31 | (5.4) |
| II | 145 | (25.2) |
| III | 283 | (49.1) |
| IVa-b | 117 | (20.3) |
| Mean dose to GTVnx (Gy) | ||
| Median (range) | 74.29 (63.56-79.81) | |
| Chemotherapy | ||
| CCRT alone | 236 | (41.0) |
| NACT+CCRT | 121 | (21.0) |
| CCRT+ACT | 2 | (0.4) |
| NACT alone | 15 | (2.6) |
| ACT alone | 2 | (0.4) |
| No chemotherapy | 200 | (34.7) |
§
According to the 2005 classification.
*
According to the UICC/AJCC TNM staging system 7th edition.